Evidence map›Paper›PMID 40620027›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

Controlling Nanonet Morphology via Residue-Specific Modulation of β-Hairpin Peptide for Enhanced Bacterial Trapping.

Wei Meng Chen, Dhanya Mahalakshmi Murali, Nhan Dai Thien Tram, Peiyan Yu, Daniel Tianyu Wang, Pui Lai Rachel Ee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei Meng ChenDepartment of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.ORCID 0009-0000-6838-9276
Dhanya Mahalakshmi MuraliDepartment of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.ORCID 0009-0005-0304-6383
Nhan Dai Thien TramDepartment of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.ORCID 0000-0003-3875-2315
Peiyan YuDepartment of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.ORCID 0000-0002-1684-4131
Daniel Tianyu WangDepartment of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.ORCID 0009-0004-5939-1787
Pui Lai Rachel EeDepartment of Pharmacy and Pharmaceutical Sciences, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.ORCID 0000-0002-7277-6233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise control over peptide nanonet architecture is instrumental in advancing the development of antibacterial nanonets. Here, a novel design strategy is presented to control bacteria nanonet morphology through rational modification of the β-hairpin side strands, leveraging the unique chemical properties of amino acid side chains. By fine-tuning both the termini and aromaticity of the hydrophobic residue, the W-W

Indexed as

Anti-Bacterial AgentsNanofibersPeptidesAmino AcidsEscherichia coliHydrophobic and Hydrophilic InteractionsPseudomonas aeruginosaStaphylococcus aureusAmino AcidsAnti-Bacterial AgentsPeptidesamyloid beta‐peptidesantimicrobial peptidesbacteria trappingnanonetsself‐assembly

Identifiers

PMID40620027
PMCPMC12410913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.